Article Details

Ensysce Biosciences Announces First Patients Enrolled in Phase 1 Study of PF614-MPAR ...

Retrieved on: 2021-12-15 21:06:51

Tags for this article:

Click the tags to see associated articles and topics

Ensysce Biosciences Announces First Patients Enrolled in Phase 1 Study of PF614-MPAR .... View article details on hiswai:

Excerpt

(“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technology platforms that may provide new hope ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up